
ReCET Study | Type 2 Diabetes | Clinical Trial
What is the ReCET Procedure? The ReCET Procedure is a non-surgical, investigational treatment designed to improve blood sugar control in adults with Type 2 Diabetes.
ReCET Treatment by Endogenex
The ReCET Study is a pivotal clinical study evaluating the use of the Endogenex System in people living with type 2 diabetes. The ReCET Study will be enrolling participants at clinical sites in the United …
Researchers study novel endoscopic therapy for type 2 diabetes
Feb 24, 2024 · Endoscopic re-cellularization via electroporation therapy (ReCET), also known as endoscopic duodenal mucosal regeneration, is a novel endoscopic procedure and device developed …
Endogenex offers ReCET system study results for type 2 diabetes
May 3, 2025 · Endogenex will present results today of a trial studying its ReCET pulsed electric field (PEF) system in type 2 diabetes patients, saying the investigational procedure “demonstrates …
The ReCET Study is a clinical research study evaluating the non-surgical ReCETTMProcedure to find out if it can help lower or better control blood sugar levels in people with Type 2 Diabetes.
Diabetes Breakthrough: New Treatment Eliminates Insulin
Oct 17, 2024 · This innovative approach, which combines a novel procedure known as ReCET (Re-Cellularization via Electroporation Therapy) with semaglutide, resulted in the elimination of insulin …
Endoscopic Intestinal Re-Cellularization Therapy in Type II Diabetes ...
The ReCET device is designed to treat the lining of the first part of the small intestine (duodenum) in order to improve blood sugar control in individuals with T2D. The procedure is done through the …
898 - RECET: A Multicenter, Double-blind, Sham-controlled Study for ...
Study Purpose: To study changes in blood glucose control and weight loss in Type II Diabetics using Nutrition and Lifestyle Counseling combined with an investigational device called the ReCET …
Breakthrough in Type 2 Diabetes Treatment: Combining Semaglutide with RECET
Oct 16, 2024 · The study’s procedural framework consisted of two main components: the RECET procedure, followed by a regimen of semaglutide. RECET, or renal sympathetic denervation, was …
Endogenex designed the ReCET system to treat type 2 diabetes
Jun 20, 2025 · ReCET treats inflamed and dysfunctional tissue associated with type 2 diabetic duodenopathy, delivering nonthermal pulsed electric field (PEF) energy to mucosal and submucosal …